Galectin Therapeutics Inc
GALT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001133416
In the last 90 days, Galectin Therapeutics Inc insiders filed 0 open-market purchases and 1 sale; 98 institutions reported holding it in 13F filings for Q2 2026, worth $72.2M in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding Galectin Therapeutics Inc changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Of which not filed for Q2 2026 | Q2 2026 | Change |
|---|---|---|---|---|
| Holders | 99 | 1 | 98 | 0 |
| Shares | 13.9M | 139 | 15.6M | +1.69M (+12.1%) |
| Value | $38.8M | $388 | $72.2M | +$33.4M (+86.3%) |
1 institution that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so the changes leave them out.
New holders (20)
Institutions that held Galectin Therapeutics Inc at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Vanguard Portfolio Management LLC | 327,766 | $1.52M | 0.00% |
| National Bank of Canada | 167,900 | $779.1K | 0.00% |
| Bank of New York Mellon Corp | 105,742 | $490.6K | 0.00% |
| Nuveen, LLC | 63,710 | $295.6K | 0.00% |
| Rhumbline Advisers | 48,332 | $224.3K | 0.00% |
| Deutsche Bank AG | 47,403 | $219.9K | 0.00% |
| Price T Rowe Associates Inc | 39,313 | $183.0K | 0.00% |
| MetLife Investment Management | 28,875 | $134.0K | 0.00% |
| Mirae Asset Global ETFs Holdings Ltd. | 22,066 | $102.4K | 0.00% |
| XTX Topco Ltd | 14,422 | $66.9K | 0.00% |
| Police & Firemen's Retirement System of New Jersey | 14,133 | $65.6K | 0.00% |
| Group One Trading, L.P. | 13,753 | $63.8K | 0.00% |
| New York State Common Retirement Fund | 13,600 | $63.1K | 0.00% |
| Alliancebernstein L.P. | 11,200 | $31.2K | 0.00% |
| Legal & General Group Plc | 4,662 | $21.6K | 0.00% |
| Ameritas Investment Partners, Inc. | 4,349 | $20.2K | 0.00% |
| California State Teachers Retirement System | 660 | $3.06K | 0.00% |
| Sterling Capital Management LLC | 417 | $1.94K | 0.00% |
| Fortitude Family Office, LLC | 372 | $1.73K | 0.00% |
| Global Retirement Partners, LLC | 250 | $1.16K | 0.00% |
Sold out (20)
Institutions that held Galectin Therapeutics Inc at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Vivaldi Capital Management, LLC | 258,584 | $721.4K |
| Jane Street Group, LLC | 194,868 | $543.7K |
| 683 Capital Management, LLC | 162,484 | $453.3K |
| Qube Research & Technologies Ltd | 126,439 | $352.8K |
| Hudson Bay Capital Management LP | 74,728 | $208.5K |
| HRT Financial LP | 51,058 | $142.0K |
| Wiley Bros.-Aintree Capital, LLC | 41,000 | $114.4K |
| Brevan Howard Capital Management LP | 35,585 | $99.3K |
| Omers Administration Corp | 24,100 | $67.2K |
| Catalyst Funds Management Pty Ltd | 22,500 | $62.8K |
| Nine Masts Capital Ltd | 19,324 | $53.9K |
| Engineers Gate Manager LP | 18,739 | $52.3K |
| Diametric Capital, LP | 17,089 | $47.7K |
| Colony Group, LLC | 13,897 | $38.8K |
| Jefferies Financial Group Inc. | 12,188 | $34.0K |
| Mercer Global Advisors Inc | 10,113 | $28.2K |
| Sound Income Strategies, LLC | 2,980 | $7.99K |
| MAI Capital Management | 1,000 | $2.79K |
| Hamrick Investment Counsel, llc | 100 | $279 |
| True Wealth Design, LLC | 2 | $6 |
Not filed for Q2 2026 yet (1)
Institutions that held Galectin Therapeutics Inc at the end of Q1 2026 and haven't filed a 13F for Q2 2026. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| CWM, LLC | 139 | $388 |